Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Doyle

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Virus Eradication|August 3, 2016
The evolving role of interferons in viral eradication strategiesTomas Doyle
Current Opinion in Infectious Diseases|December 14, 2011
Low-level viraemia on HAART: significance and managementTomas Doyle, Anna Maria Geretti
Current Opinion in Infectious Diseases|December 2, 2009
Immunization for HIV-positive individualsAnna Maria Geretti, Tomas Doyle
Current Opinion in Infectious Diseases|June 18, 2009
Haemophagocytic syndrome and HIVTomas Doyle, Sanjay Bhagani, Kate Cwynarski
Nature Reviews. Microbiology|April 28, 2015
HIV-1 and interferons: who's interfering with whom?Tomas Doyle, Caroline Goujon, Michael H Malim
Journal of Virology|February 13, 2015
A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2Caroline Goujon, Rebecca A Greenbury, Stelios Papaioannou, et al.
Journal of Virology|June 6, 2014
Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factorCaroline Goujon, Olivier Moncorgé, Hélène Bauby, et al.
AIDS (London, England)|February 5, 2011
Detecting HIV-1 superinfection by pol gene population sequencing among untreated HIV-1-infected men who experience sudden rises in plasma HIV-1 RNA loadTomas Doyle, Ana M Garcia-Diaz, John Ambrose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapyTomas Doyle, Colette Smith, Paola Vitiello, et al.
Journal of Medical Case Reports|March 9, 2010
Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case reportRobin H Johns, Tomas Doyle, Marc C Lipman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Virus Eradication|August 3, 2016
The evolving role of interferons in viral eradication strategiesTomas Doyle
Current Opinion in Infectious Diseases|December 14, 2011
Low-level viraemia on HAART: significance and managementTomas Doyle, Anna Maria Geretti
Current Opinion in Infectious Diseases|December 2, 2009
Immunization for HIV-positive individualsAnna Maria Geretti, Tomas Doyle
Current Opinion in Infectious Diseases|June 18, 2009
Haemophagocytic syndrome and HIVTomas Doyle, Sanjay Bhagani, Kate Cwynarski
Nature Reviews. Microbiology|April 28, 2015
HIV-1 and interferons: who's interfering with whom?Tomas Doyle, Caroline Goujon, Michael H Malim
Journal of Virology|February 13, 2015
A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2Caroline Goujon, Rebecca A Greenbury, Stelios Papaioannou, et al.
Journal of Virology|June 6, 2014
Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factorCaroline Goujon, Olivier Moncorgé, Hélène Bauby, et al.
AIDS (London, England)|February 5, 2011
Detecting HIV-1 superinfection by pol gene population sequencing among untreated HIV-1-infected men who experience sudden rises in plasma HIV-1 RNA loadTomas Doyle, Ana M Garcia-Diaz, John Ambrose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapyTomas Doyle, Colette Smith, Paola Vitiello, et al.
Journal of Medical Case Reports|March 9, 2010
Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case reportRobin H Johns, Tomas Doyle, Marc C Lipman, et al.
Pageof 2